- Home
- AVAH vs TSHA Comparison
AVAH vs TSHA Comparison
Compare AVAH & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVAH
- TSHA
- Stock Information
- Founded
- AVAH 1984
- TSHA 2019
- Country
- AVAH United States
- TSHA United States
- Employees
- AVAH N/A
- TSHA N/A
- Industry
- AVAH Hospital/Nursing Management
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- AVAH Health Care
- TSHA Health Care
- Exchange
- AVAH Nasdaq
- TSHA Nasdaq
- Market Cap
- AVAH 872.6M
- TSHA 728.4M
- IPO Year
- AVAH 2021
- TSHA 2020
- Fundamental
- Price
- AVAH $7.47
- TSHA $3.00
- Analyst Decision
- AVAH Buy
- TSHA Strong Buy
- Analyst Count
- AVAH 5
- TSHA 7
- Target Price
- AVAH $7.50
- TSHA $8.71
- AVG Volume (30 Days)
- AVAH 1.8M
- TSHA 2.6M
- Earning Date
- AVAH 08-07-2025
- TSHA 08-12-2025
- Dividend Yield
- AVAH N/A
- TSHA N/A
- EPS Growth
- AVAH N/A
- TSHA N/A
- EPS
- AVAH 0.09
- TSHA N/A
- Revenue
- AVAH $2,177,672,000.00
- TSHA $8,098,000.00
- Revenue This Year
- AVAH $9.80
- TSHA N/A
- Revenue Next Year
- AVAH $4.77
- TSHA N/A
- P/E Ratio
- AVAH $78.74
- TSHA N/A
- Revenue Growth
- AVAH 11.54
- TSHA N/A
- 52 Week Low
- AVAH $3.67
- TSHA $1.05
- 52 Week High
- AVAH $7.66
- TSHA $3.31
- Technical
- Relative Strength Index (RSI)
- AVAH 77.99
- TSHA 63.38
- Support Level
- AVAH $7.03
- TSHA $2.76
- Resistance Level
- AVAH $7.61
- TSHA $3.05
- Average True Range (ATR)
- AVAH 0.47
- TSHA 0.15
- MACD
- AVAH 0.16
- TSHA 0.00
- Stochastic Oscillator
- AVAH 94.43
- TSHA 75.51
About AVAH Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.